CD8+ regulatory T cells in solid organ transplantation

Current Opinion in Organ Transplantation

Volumn 15, Issue 6, 2010, Pages 751-756

  Guillonneau, Carole ^a   Picarda, Elodie ^a   Anegon, Ignacio ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

CD8 regulatory T cells; tolerance; transplantation

Indexed keywords

BIOLOGICAL MARKER; PERFORIN; T LYMPHOCYTE RECEPTOR;

ALLOGRAFT; ANTIGEN SPECIFICITY; CD8+ T LYMPHOCYTE; CELL THERAPY; CYTOTOXICITY; EX VIVO STUDY; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NONHUMAN; ORGAN TRANSPLANTATION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; TARGET CELL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; ORGAN TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL;

EID: 78649637232     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834016d1     Document Type: Review

References (80)

1. Gershon RK, Kondo K. Cell interactions in the induction oftolerance: the role ofthymic lymphocytes. Immunology 1970; 18:723-737.
2. Cantor H,Shen FW, Boyse EA. Separation ofhelperTcellsfromsuppressor T cells expressing different Ly components. II: Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J Exp Med 1976; 143:1391-1440.
3. Bushell A, Jones E, Gallimore A, et al. The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen. J Immunol 2005; 174:3290-3297.
4. + T cells exhibit selective suppressive capacity. Eur J Immunol 2009; 39:2703-2715.
5. Zheng J, Liu Y, Qin G, et al. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J Immunol 2009; 183:3742-3750.
6. + regulatory T cells by continuous antigen stimulation. Eur J Immunol 2008; 38:640-646.
7. Fowler DH, Breglio J, Nagel G, et al. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J Immunol 1996; 157:4811-4821.
8. Martin PJ. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implicationsfor marrowtransplantation in humans. J Exp Med 1993; 178:703-712.
9. Najafian N, Chitnis T, Salama A D, et al. Regulatoryfunctions ofCD8+CD28? T cells in an autoimmune disease model. J Clin Invest 2003; 112:1037-1048.
10. Hu D, Ikizawa K, Lu L, et al. Analysisofregulatory C D8Tcellsin Qa-1-deficient mice. Nat Immunol 2004; 5:516-523.
11. + T cells. Proc Natl Acad Sci USA 1998; 95:4533-4537.
12. Sarantopoulos S, Lu L, Cantor H. Qa-1 restriction of CD8+ suppressor T cells. J Clin Invest 2004; 114:1218-1221.
13. Bienvenu B, Martin B, Auffray C, et al. Peripheral CD8+CD25+ T lympho-cytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 2005; 175:246-253.
14. Aandahl EM, Torgersen KM, Tasken K. CD8+ regulatory T cells-A distinct T-cell lineage or a transient T-cell phenotype? Hum Immunol 2008; 69:696-699.
15. Fontenot JD, Dooley JL, Farr AG, et al. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005; 202:901-906.
16. Fontenot JD, Rasmussen JP, Williams LM, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329-341.
17. Ordonez L, Bernard I, L'Faqihi-Olive FE, et al. CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients. PLo S One 2009; 4:e5287.
18. Xystrakis E, Cavailles P, Dejean AS, et al. Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat. J Immunol 2004; 173:3140-3147.
19. Menager-Marcq I, Pomie C, Romagnoli P, et al. CD8+CD28\regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gas-troenterology 2006; 131:1775-1785.
20. Ho J, Kurtz CC, Naganuma M, et al. A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis. J Immunol 2008; 180:2573-2580.
21. Rifa'i M, Kawamoto Y, Nakashima I, et al. Essential roles of CD8+CD122+ regulatoryT cells in the maintenance of T cell homeostasis. J Exp Med 2004; 200:1123-1134.
22. Endharti AT, Rifa IM, Shi Z, et al. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 2005; 175:7093-7097.
23. Chen X, Priatel JJ, Chow MT, et al. Preferential development of CD4 and CD8 T regulatory cells in RasGR P1-deficient mice. J Immunol 2008; 180:5973-5982.
24. Dai H, Wan N, Zhang S, et al. Cutting edge: programmed death-1 defines CD8+CD122+Tcellsas regulatory versus memoryTcells. J Immunol 2010; 185:803-807.
25. Koehn BH, Ford ML, Ferrer IR, et al. PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. J Immunol 2008; 181:5313-5322.
26. Haspot F, Fehr T, Gibbons C, et al. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. Blood 2008; 112:2149-2155.
27. Seo SK, Choi JH, Kim YH, et al. 4-1BB-mediated immunotherapy of rheu-matoid arthritis. Nat Med 2004; 10:1088-1094.
28. Lu L, Cantor H. Generation and regulation of CD8(+) regulatory T cells. Cell Mol Immunol 2008; 5:401-406.
29. Li J, Goldstein I, Glickman-Nir E, et al. Induction ofTCRVbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. J Immunol 2001; 167:3800-3808.
30. Varthaman A, Khallou-Laschet J,Clement M, et al.Controlof Tcell reactivation by regulatory Qa-1-restricted CD8+ T cells. J Immunol 2010.
31. Guillonneau C, Hill M, Hubert FX, et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J Clin Invest 2007; 117:1096-1106.
32. Xystrakis E, Dejean AS, Bernard I, et al. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 2004; 104:3294-3301.
33. Cortesini NS, Colovai AI, Manavalan JS, et al. Role of regulatory and suppressor T-cells in the induction of ILT3+ ILT4+ tolerogenic endothelial cells in organ allografts. Transpl Immunol 2004; 13:73-82.
34. Liu J, Liu Z, Witkowski P, et al. Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 2004; 13:239-247.
35. Sewgobind VD, van der Laan LJ, Kho MM, et al. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease. Transplantation 2010; 89:655-666.
36. Kapp JA, Honjo K, Kapp LM, et al. TCRtransgenic CD8+T cells activated in the presence of TGFbeta express Fox P3 and mediate linked suppression of primary immune responses and cardiac allograft rejection. Int Immunol 2006; 18:1549-1562.
37. Zhou J, Appleton SE, Stadnyk A, et al. CD8+ gammadelta T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen. Transpl Int 2008; 21:679-687.
38. Sireci G, Barera A, Macaluso P, et al. A continuous infusion of a minor histocompatibility antigen-immunodominant peptide induces a delay of male skin graft rejection. Immunobiology 2009; 214:703-711.
39. Liu H, Shalev I, Manuel J, et al. The FGL2-FcgammaRII B pathway: a novel mechanism leading to immunosuppression. Eur J Immunol 2008; 38:3114-3126.
40. Shalev I, Liu H, Koscik C, et al. Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J Immunol 2008; 180:249-260.
41. Li XL, Menoret S, Bezie S, et al. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J Immunol 2010.
42. Rifa'i M, Shi Z, Zhang SY, et al. CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. Int Immunol 2008; 20:937-947.
43. Shi Z, Rifa'i M, Lee Y H, et al. Importance ofCD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells. Immunology 2008; 124:121-128.
44. Guillonneau C, Seveno C, Dugast AS, et al. Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients. J Immunol 2007; 179:8164-8171.
45. Izawa A, Yamaura K,Albin MJ, et al. A novel alloantigen-specific CD8+PD1 + regulatory T cell induced by ICOS-B7h blockade in vivo. J Immunol 2007; 179:786-796.
46. Shi Z, Okuno Y, Rifa'i M, et al. Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg. Eur J Immunol 2009; 39:2106-2119.
47. Lu L, Kim HJ, Werneck MB, et al. Regulation of CD8+ regulatory T cells: interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc Natl Acad Sci USA 2008; 105:19420-19425.
48. Lu L, Ikizawa K, Hu D, et al. Regulation ofactivated CD4+T cells by NKcells via the Qa-1-NKG2A inhibitory pathway. Immunity 2007; 26:593-604.
49. Yamada Y, Sugita S, Horie S, et al. Mechanisms of immune suppression for CD8+ T cells by human corneal endothelial cells via membrane-bound TGFbeta. Invest Ophthalmol Vis Sci 2010; 51:2548-2557.
50. Wang J, Jiang S, Shi H, et al. Prolongation of corneal xenotransplant survival by T-cell vaccination-induced T-regulatory cells. Xenotransplantation 2008; 15:164-173.
51. Velthuis JH, Unger WW, van der Slik A R, et al. Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreasallo graft of a type 1 diabetic recipient. Diabetologia 2009; 52:494-503.
52. Koch SD, Uss E, van Lier RA, et al. Alloantigen-induced regulatory CD8+CD103+ T cells. Hum Immunol 2008; 69:737-744.
53. Uss E, Yong SL, Hooibrink B, et al. Rapamycin enhances the number of alloantigen-induced human CD103+CD8+ regulatory T cells in vitro. Trans-plantation 2007; 83:1098-1106.
54. + regulatory T cells in spontaneous tolerance of liver allografts. Int Immunopharmacol 2009; 9:546-548.
55. Fehr T, Lucas CL, Kurtz J, et al.A CD8 Tcell-intrinsic roleforthe calcineurin-NFAT pathway for tolerance induction in vivo. Blood 2010; 115:1280-1287.
56. Hsieh CS, Rudensky AY. The role of TCR specificity in naturally arising CD25+ CD4+ regulatory T cell biology. Curr Top Microbiol Immunol 2005; 293:25-42.
57. Josefowicz SZ, Wilson CB, Rudensky AY. Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. J Immunol 2009; 182:6648-6652.
58. Wu Y, Zheng Z, Jiang Y, et al. The specificity of T cell regulation that enables self-nonself discrimination in the periphery. Proc Natl Acad Sci USA 2009; 106:534-539.
59. Jiang H, Chess L. Qa-1/HLA-E-restricted regulatory CD8+ T cells and self-nonselfdiscrimination: an essay on peripheralT-cell regulation. Hum Immunol 2008; 69:721-727.
60. Burlingham WJ, Goulmy E. Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens. Hum Immunol 2008; 69:728-731.
61. Bisikirska B, Colgan J, Luban J, et al. TCRstimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005; 115:2904-2913.
62. Lathrop SK, Santacruz NA, Pham D, et al. Antigen-specific peripheral shaping of the natural regulatory T cell population. J Exp Med 2008; 205:3105-3117.
63. Kapp JA, Honjo K, Kapp LM, et al. Antigen, in the presence of TGF-beta, induces up-regulation of Fox P3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses. J Immunol 2007; 179:2105-2114.
64. Kapp JA, Bucy RP. CD8+ suppressor T cells resurrected. Hum Immunol 2008; 69:715-720.
65. Masteller EL, Tang Q, Bluestone JA. Antigen-specific regulatory T cells: ex vivo expansion and therapeutic potential. Semin Immunol 2006; 18:103-110.
66. Brusko T, Bluestone J. Clinical application of regulatoryTcellsfortreatmentof type 1 diabetes and transplantation. Eur J Immunol 2008; 38:931-934.
67. Zhang J. Yin and yang interplay of IFN-gamma in inflammation and auto-immune disease. J Clin Invest 2007; 117:871-873.
68. Lin YX, Yan LN, Li B, et al. A significant expansion of CD8+ CD28-T-suppressor cells in adult-to-adult living donor liver transplant recipients. Transplant Proc 2009; 41:4229-4231.
69. Lin YX, Wang LL, Yan LN, et al. Analysis ofCD8+CD28? T-suppressorcells in living donor livertransplant recipients. Hepatobiliary Pancreat Dis Int 2009; 8:241-246.
70. Kim-Schulze S, Scotto L, Vlad G, et al. Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells. J Immunol 2006; 176:2790-2798.
71. Vlad G, D'Agati VD, Zhang QY, et al. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice. Diabetes 2008; 57:1878-1886.
72. Vlad G, Stokes MB, Liu Z, et al. Suppression of xenogeneic graft-versus-host disease by treatment with immunoglobulin-like transcript 3-Fc. Hum Immunol 2009; 70:663-669.
73. Vlad G, Chang CC, Colovai AI, et al. Membraneand soluble ILT3arecritical to thegeneration ofTsuppressorcellsand induction of immunologi caltolerance. Int Rev Immunol 2010; 29:119-132.
74. Qin H, Vlad G, Cortesini R, et al. CD8+ suppressor and cytotoxic T cells recognize the same human leukocyte antigen-A2 restricted cytomegalovirus peptide. Hum Immunol 2008; 69:776-780.
75. +CD28? T cells. Transpl Immunol 2010; 22 (3-4):144-149.
76. Tsai S, Shameli A, Yamanouchi J, et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 2010; 32:568-580.
77. Wang J, Tsai S, Shameli A, et al. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation. Proc Natl Acad Sci USA 2010; 107:9317-9322.
78. + regulatoryTcells: therapyfortype 1 diabetes? Immunity 2010; 32:504-506.
79. Riley J L, June CH, Blazar B R. Human T regulatory cell therapy: takea billion or so and call me in the morning. Immunity 2009; 30:656-665.
80. Long E, Wood KJ. Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation 2009; 88:1050-1056.